White House and China Highlight Different Outcomes from TrumpXi Summit Soybean and Rare Earths Deals Tariff Cut Signals Nvidia Slumps After Earnings Beat Data Center Demand Surge Fuels Market Caution South Koreas Deputy PM Warns AIDriven Wealth Must Be Shared Broadly Amid Labor Unrest at Samsung Bungie to End Destiny 2 Major Updates Game to Remain Playable Implications for Sonys Gaming Segment Child Life Specialist Shares 6 Phrases That Strengthen People Skills A Lesson for Professionals NYTs Pips Puzzle Walkthrough Highlights Growing Role of Games in Subscription Strategy TaskUs TASK Q1 2026 Earnings EPS Slightly Misses Estimates Amid Modest Revenue Headwinds AVGO Q1 2026 Earnings Narrow EPS Miss Amid Modest Market Response Seabridge Gold Q1 2024 Earnings Net Loss per Share Reported Stock Edges Higher CRDF Q1 2026 Earnings EPS Misses Estimates Stock Rises on Pipeline Progress Old Republic International ORI Q1 2026 Earnings EPS Misses Estimates Stock Falls 171 ARCO Q1 2026 Earnings Profit Surges Past Estimates on Operational Strength Yet Shares Slide Chemours CC Rallies 34 as Stock Approaches Key Resistance Level EPAM Systems Holds Steady Above Key Support After Modest Gain Rising Dragon Acquisition Corp RDAC Edges Higher Amid Quiet Trading ArriVent BioPharma AVBP Eases 168 Support at 261 in Focus After Sector Headwinds Heritage Commerce Corp HTBK Holds Steady at 1345 as Trading Remains RangeBound AWI Q1 2026 Earnings EPS Falls Short as Revenue Picture Remains Unclear Viking Holdings VIK Q1 2026 Earnings NarrowerthanExpected Loss Surprises Market MBINL Q1 2026 Earnings EPS Beats Estimates by 502 Amid Strong Operational Performance GHM Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus CFFN Q1 2026 Earnings EPS Misses Estimates Amid Narrowing Net Interest Margin Fed Minutes Reveal Officials Anticipate Rate Hikes If Inflation Persists CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses RPC Inc Faces Selling Pressure as Shares Decline 407 Key Support Levels in Focus